Venture Fellow, BrightEdge of the American Cancer Society.
Josh Peters is currently a Ph.D. candidate at MIT in Biological Engineering, affiliated with the Broad Institute of MIT and Harvard and the Ragon Institute of MGH, MIT, and Harvard.
His research focuses understanding and engineering innate immune cells in lung diseases. Prior to joining BrightEdge, Josh was a Bio-IT Fellow at 8VC. Josh graduated with a B.S. in chemical engineering from the University of Pittsburgh.